NCT03769870View on ClinicalTrials.gov

Teneligliptin and Atorvastatin DDI Study

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 11, 2019

Primary Completion Date

February 25, 2019

Study Completion Date

February 25, 2019

Conditions
Diabete Mellitus
Interventions
DRUG

Teneligliptin 20mg/day

cross-over

DRUG

Atorvastatin 40mg/Day

cross-over

DRUG

Teneligliptin 20mg/day + Atorvastatin 40mg/day

cross-over

Trial Locations (1)

Unknown

Korea Universitiy Guro Hospital, Seoul

Sponsors

Lead Sponsor

Handok Inc.
All Listed Sponsors
lead

Handok Inc.

INDUSTRY

NCT03769870 - Teneligliptin and Atorvastatin DDI Study | Biotech Hunter | Biotech Hunter